FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow

Journal of Experimental Medicine

Volumn 194, Issue 5, 2001, Pages 581-589

  Keller, P ^a   Payne, J L ^a   Tremml, G ^a   Greer, P A ^a   Gaboli, M ^a   Pandolfi, P P ^a   Bessler, M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C fes; Conditional gene inactivation; Hematopoiesis; Paroxysmal nocturnal hemoglobinuria; Stem cell

Indexed keywords

CRE RECOMBINASE; PROTEIN; PROTEIN KINASE FES; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE INACTIVATION; GENE TARGETING; GENETIC RECOMBINATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; BONE MARROW CELLS; COLONY-FORMING UNITS ASSAY; FEMALE; FETAL DEATH; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMATOPOIETIC STEM CELLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; INTEGRASES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; PREGNANCY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FES; PROTO-ONCOGENES; RECOMBINATION, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 0035801698     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.5.581     Document Type: Article

References (31)

1. Paroxysmal nocturnal hemoglobinuria as a molecular disease
2. Paroxysmal nocturnal haemoglobinuria
3. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria
4. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene
5. The first step of glycosylphosphatidylinositol biosynthesis is mediated by a complex of PIG-A, PIG-H, PIG-C and GPI1
6. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein
7. Glycosylphosphatidylinositol-anchor-deficient mice: Implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria
8. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion
9. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1
10. Conditional genome alteration in mice
11. Conditional gene targeting
12. Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells
13. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells
14. c-fes expression in ontogenetic development and hematopoietic differentiation
15. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice
16. Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis
17. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice
18. The genetic program of hematopoietic stem cells
19. The structure of the human c-fes/fps protooncogene
20. Myeloid expression of the human c-fps/fes protooncogene in transgenic mice
21. A minimal c-fes cassette directs myeloid-specific expression in transgenic mice
22. Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene
23. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose
24. X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation
25. Selective expression of an acetylcholine receptor-lacZ transgene in synaptic nuclei of adult muscle fibers
26. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin
27. PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation
28. Solubility and posttranslational regulation of GP130/F11 - A neuronal GPI-linked cell adhesion molecule enriched in the neuronal membrane skeleton
29. Membrane dynamics of the phosphatidylinositol-anchored form and the transmembrane form of the cell adhesion protein LFA-3
30. A critical role for PU.1 in homing and long-term engraftment by hematopoietic stem cells in the bone marrow
31. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor